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Background: Melastoma malabathricum L. (Melastomaceae) is a small shrub with various medicinal uses. The present
study was carried out to determine the gastroprotective mechanisms of methanol extract of M. malabathricum leaves
(MEMM) in rats.
Methods: The extract's mechanisms of gastroprotection (50, 250, 500 mg/kg) were studied using the pylorus-ligation in
rat model wherein volume, pH, free and total acidity of gastric juice, and gastric wall mucus content were determined.
The involvement of endogenous nitric oxide (NO) and sulfhydryl (SH) compounds in the gastroprotective effect of
MEMM were also measured. MEMM was subjected to the antioxidant, anti-inflammatory and phytochemical analysis
and HPLC profiling.
Results: MEMM contained various phyto-constituents with quercitrin being identified as part of them. MEMM and
quercitrin: i) significantly (p < 0.05) reduced the volume and acidity of gastric juice while increasing the pH and
gastric wall mucus content.; ii) significantly (p < 0.05) increased the level of SOD, GTP and GTR while significantly
(p < 0.05) reduced the level of CAT, MPO and TBARS activities.; iii) exerted gastroprotective activity when assessed
using the ethanol-induced gastric ulcer assay, which was reversed by NG-nitro-L-arginine methyl esters (L-NAME;
an inhibitor of NO synthase) and N-ethylmaleimide (NEM; a sulfhydryl (SH) blocker). MEMM inhibited the
lipoxygenase (LOX) and xanthine oxidase (XO) activities with the highest affinity for the former while quercitrin
showed high affinity for XO activity.
Conclusions: MEMM exhibited a gastroprotective activity due partly to the presence of quercitrin, its antioxidant
and anti-inflammatory activities, and via the modulation of NO and SH groups.
Keywords: Melastoma malabathricum, Melastomaceae, Methanol extract, Gastroprotective mechanisms, Nitric
oxide, Sulfhydryl group, Antioxidant, Anti-inflammatoryBackground
Peptic ulcers are a common disorder of the entire
gastrointestinal tract. Of nearly 8 to 10% of the global
population affected by peptic ulcers, approximately 5%
of them suffer from gastric ulcers [1]. The ulcers that
affect the gastrointestinal system are usually aggravated
by a disproportion between destructive and defensive
factors in the stomach [1]. Although considered as
multifactorial disease, it is generally acknowledged that* Correspondence: dr_zaz@yahoo.com
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Helicobacter pylori and the major therapeutic aim is to
eradicate the H. pylori infection. Currently, the first-line
medical treatment of gastric ulcer is targeted at eradicating
H. pylori infection and usually based on triple treatment
procedure, which involved the use of gastric ulcer inhib-
itors (I.e. histamine H2-antagonists, proton pump inhib-
itors, or sucralfate and bismuth) in combination with
two types of antibiotics [2]. However, the fact that there
are various factors other than H. pylori that can trigger
gastric ulcer formation should not be ignored [3].
Various approaches have been used in the treatment of
gastric ulcer associated with those non-H. pylori-relatedrticle distributed under the terms of the Creative Commons Attribution License
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mucus production but these approaches have been
regarded as the second-line treatment.
Despite their effectiveness in eradicating H. pylori, the
treatment is complex and of high cost, involving the use
of at least two antibiotics in combination with gastric
acid inhibitors. This combination often causes several
unwanted side effects (i.e. antibiotic resistance, recur-
rence, nausea) [2,3]. Despite the fact that H. pylori infec-
tions have gradually declined throughout the majority of
industrialized countries, a gradual increase in failure of
H. pylori eradication treatments is observed elsewhere
[2]. This is further worsen by the association of those
standard antiulcer agents with various unwanted side
effects. In consideration of their diverse adverse effects
and the occurrence of antibiotic-resistant H. pylori strains,
the search for new and safe non-antibiotic gastroprotec-
tive agents from natural sources, particularly plants, con-
tinue to increase all over the world [2,4].
One of the plants that are used to treat gastric ulcer in
Malaysia is Melastoma malabathricum L. (family Mela-
stomaceae). Locally known to the Malay as ‘Senduduk’ ,
M. malabathricum is found abundantly in Indian Ocean
Island, throughout South and Southeast Asia, Taiwan,
China, South Pacific Ocean and Australia. Various parts
of the plant are used in Malay traditional medicines to
treat a variety of ailments with the leaves, in particular,
have been used to treat gastric ulcers among others [5].
Scientifically, the M. malabathricum parts have been
reported to exhibit various pharmacological activities
[5-7]. Other than for its traditional use as antiulcer
agent, M. malabathricum was chosen in the present
study based on the fact that it is one of the famous herbs
in Malay medicinal folklore, but received lack of attention
among the community. Moreover, M. malabathricum has
been reported to contain high total phenolic content and
to exert high antioxidant and anti-inflammatory activities
[5-7], which are important in the mechanisms of antiulcer
of any compounds/extracts. It is well known that gastric
ulcer, particularly those induce by ethanol, is associated
with ROS generation. Ethanol rapidly penetrates the
gastric mucosa as it is able to solubilize the protective
mucous and causes the release of hydroperoxy-free
radicals and superoxide anion. These free radicals cause
an increase in oxidative stress in the tissues, which in turn,
increases the level of malondialdehyde, a marker of
increased lipid peroxidation. Overall, ethanol-induced
deleterious effect can be manifested directly via gener-
ation of reactive metabolites or indirectly via activation
other mechanisms that finally trigger oxidative damage
[7]. Hence, extracts/compounds with antioxidants activity
play a very important role in scavenging those free
radicals and inhibit lipid peroxidation. In lieu of this,
M. malabathricum has been reported to exert aremarkable antioxidant activity [7] and, therefore, is be-
lieved to possess antiulcer potential. Our earlier screening
of methanol extract of M. malabathricum (MEMM) for
antiulcer potential against ethanol- and indomethacin-
induced gastric ulcer models has been reported elsewhere
[8]. MEMM was found to attenuate ethanol-induced, but
aggravated indomethacin-induced, gastric ulcer formation.
The ability of MEMM to exert both the gastroprotection
and anti-inflammatory activities [5] is in contrast to that
of indomethacin, which only exerted anti-inflammatory
activity. This observation seems to suggest that the extract
activates gastroprotection via a mechanism that is not
associated to that of anti-inflammation. Moreover, the
anti-inflammatory activity of MEMM might possibly dif-
fered from the one exerted by indomethacin. Being an
inhibitor of both COXs (i.e. COX-1 and COX-2), indo-
methacin is more selective for COX-1, which is required
for maintaining the protective gastric mucosal layer [9].
The ability of MEMM to intensify indomethacin-induced
gastric ulcer formation suggests that MEMM might also
inhibited COX-1 action and interfere with the formation
of constitutive PG that help to protect the gastric mucosa
among others. On the other hand, the ability of MEMM
to exert anti-inflammatory activity might be due to its
ability to inhibit the COX-2-dependent response associ-
ated with the carrageenan-induced rat’s paw edema test
[5;9]. Other than that, MEMM might also work contrarily
by activating COX-2, leading to increase PGE2 synthesis,
which has been reported to exert anti-inflammatory
activity by binding to one of its receptors, the PGE re-
ceptor 4 (EP4) [10]. Furthermore, PGE2 has been known
to be the precursor for the formation of cyclopentenone
prostaglandins (cyPG) that exerts anti-inflammatory
[11]. Moreover, the ability to activate the PGE2 synthe-
sis, which in turn increases the gastric mucus produc-
tion, can occur via the activation of the EP3 receptors
[10]. This might again help explain the ability of MEMM
to demonstrate anti-inflammatory activity while, at the
same time, exert antiulcer activity against the ethanol-, but
not indomethacin-induced model. Despite these sugges-
tions, no attempt has been made to determine the pos-
sible mechanisms of gastroprotection of MEMM, which
could be used to explain the observed antiulcer activity.
Taking into account the above-mentioned report [8]
and another reports made by Hussain et al. [6], who
assessed the antiulcer potential of aqueous extract of M.
malabathricum using only one model of gastric ulcer
(i.e. ethanol-induced model), the current investigation
were designs. Although M. malabathricum has never
been used in the treatment of H. pylori infection, which
is supported by its poor antibacterial activity [12,13], the
traditional use of the plant for the treatment of gastric
ulcer justified the presence research with hope of finding
an alternative/natural gastroprotective agent as a
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drugs used in the second-line treatment. Taking this fact
into account, the present study aimed to investigate on
the possible mechanisms of gastroprotection of MEMM
using various rats models.
Methods
Chemicals
The chemicals used in this study are of analytical grades
and had been prepared immediately before use. The
following drugs were used: ranitidine (Sigma Aldrich,
USA), quercitrin (Sigma Aldrich, USA), absolute etha-
nol (Fischer Scientific, USA), N-ethylmaleimide (NEM)
(Sigma-Aldrich, USA), NG-nitro-L-arginine methyl es-
ters (L-NAME) (Sigma-Aldrich, USA), carbenoxolone
(CBX) (Sigma-Aldrich, USA) and diethyl ether (Fischer
Scientific, USA).
Plant materials collection and preparation of MEMM
The leaves of M. malabathricum were collected between
August and September, 2010 from Serdang, Selangor,
Malaysia, and identified by a botanist from the Institute
of Bioscience (IBS), Universiti Putra Malaysia (UPM),
Serdang, Selangor, Malaysia. A voucher specimen, ACP-
0017, has been deposited at the Herbarium of the
IBS, UPM, Malaysia. The ground dried leaves (40 g) were
soaked three times at room temperature for 24 h with
methanol in the ratio of 1:20 (w/v) and the methanol
supernatant was evaporated (40°C) under reduced pres-
sure to dryness resulting in a yield of 12.8 g dried and
sticky methanol extract (percentage yielded was ≈ 32%).
Phytochemical screening and HPLC analysis of MEMM
The phytochemical screening and the HPLC analysis
of MEMM was performed according to the previously re-
ported method [7]. Phytochemical screening of MEMM
was carried out to determine the presence of flavonoids,
triterpenes,tannins, alkaloids and saponins according to
the conventional protocols as described below.
i) Flavonoids
Approximately 10.0 g of MEMM was separately boiled
for 2 to 3 min in 100 ml of water in a water-bath. To
3 ml of the filtrate, 3 ml of acid-alcohol (ethanol:water:-
concentrated hydrochloric acid in the ratio of 1:1:1),
solid magnesium (1 cm) and 1 ml of t-amyl-alcohol were
added. The mixtures were then observed for a rose-
orange or violate colour change.
ii) Triterpenes
Approximately 1.0 g of MEMM was separately extracted
for 24 h in ether. 1 ml of the filtrate was evaporated todryness and the residue redissolved in several drops
of acetic anhydride and then several drops of sulphuric
acid were added to the solution. The mixtures were then
observed for a green colour change.
iii)Tannins
Approximately 0.2 g of MEMM was separately boiled
in 5 ml of water. The mixtures were cooled and filtered.
A few drops (3 drops) of 5% ferric chloride solution were
added to the filtrate and observed for a blue-black pre-
cipitate formation.
iv) Alkaloids
Approximately 0.5 g of MEMM was separately boiled
with 10 ml of dilute hydrochloric acid (alcoholic) in a
test tube for 5 min. The mixtures were cooled and the
debris was allowed to settle. Each of the supernatant
liquids was filtered into another test tube and 1 ml of each
filtrate was taken into which three drops of Dragendorff ’s
reagent (potassium bismuth iodide solution) was added,
shaken and observed for the appearance of an orange-red
spot and a precipitate formation.
v) Saponins
Approximately 0.2 g of MEMM was shaken with water
and the mixture was observed for a persistent froth.
The HPLC analysis of MEMM was performed according
to the previous report [4] but with slight modifications. In
brief, MEMM (10 mg) was suspended in 1 ml methanol.
The solution was passed through a filter cartridge (pore
size of 0.45 μm) prior to analysis. The filtered sample was
analysed using the HPLC system consisting of the Waters
Delta 600 with 600 Controller, photodiode array detector
(Waters 996). And a Phenomenex Luna (5 μm) (Torrance,
CA, USA) column (4.6 mm i.d. × 250 mm). Two solvents
denoted as A and B were used for elution of the constitu-
ents. A was 0.1% aqueous formic acid and B was aceto-
nitrile. Initial conditions were 95% A and 5% B with a
linear gradient reaching 25% B at t = 12 min and this con-
dition was maintained for 8 min. B was reduced back to
15% at t = 22 min and maintained at this condition for an-
other 8 min (t = 30 min). At t = 35 min, the programme
returned to the initial solvent composition. The flow rate
used was 1.0 ml/min and the injection volume was 10 μl.
The column oven was set at 27°C and the eluent was
monitored at 210, 254, 280, 300, 330 and 366 nm. The
retention times, peak areas and UV spectra of the major
peaks were analyzed. The HPLC analysis was carried out
in the Laboratory of Phytomedicine, Medicinal Plants
Division, Forest Research Institute of Malaysia (FRIM),
Kepong, Malaysia.
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Male Sprague Dawley rats (180–200 g; 8–10 weeks old)
were obtained from the Veterinary Animal Unit, Faculty
of Veterinary Medicine, Universiti Putra Malaysia (UPM),
Malaysia and kept under room temperature (27 ± 2°C; 70-
80% humidity; 12 h light/darkness cycle) in the Animal
Holding Unit, Faculty of Medicine and Health Sciences,
UPM. They were supplied with food and water ad libitum
from the beginning of the experiments. The study proto-
col of the present study was approved by the Animal
House and Use Committee, Faculty of Medicine and
Health Sciences, UPM (Ethical approval no: UPM/FPSK/
PADS/BR-UUH/00449). The rats were handled in accord-
ance with current UPM guidelines for the care of labora-
tory animals and the ethical guidelines for investigations
of experimental pain in conscious animals [14]. All experi-
ments were conducted between 09.30 and 18.30 h to
minimize the effects of environmental changes. Fasting
was applied for 48 h prior to all assays wherein the rats
were allowed access to only water.
Determination of the possible mechanisms of
gastroprotection of MEMM
Pylorus ligation-induced ulceration
Pylorus ligation was carried out according to the method
by Shay et al. [15] with slight modifications. Thirty rats
were divided randomly into 5 groups (n = 6). Group-I
(control) was treated with vehicle (10% DMSO), Group-
II (positive control, ranitidine) was given at 100 mg/kg
(p.o), Group-III,-IV and-V, rats were treated with
MEMM (50, 250 and 500 mg/kg, respectively). Pylorus
ligation was performed 1 h after the administration of
the test compounds on 48 h fasted rats. Ketamine HCl
(100 mg/kg, intramuscular) and xylazine HCl (16 mg/kg,
intramuscular) were used to anesthetize the rats prior to
ligation of the pylorus. A 2 cm long incision was made
in the abdomen just below the sternum on the anesthe-
tized rats. The stomach was exposed, and a thread was
passed around the pyloric sphincter and tied in a tight
knot. Care was taken while tying the knot to avoid in-
volving blood vessels in the knot. The abdomen was su-
tured, and the skin was cleaned of any blood spots or
bleeding. The animals were sacrificed 6 h after ligation
by cervical dislocation.
Determination of volume, pH, free and total acidity
of gastric content The stomachs were removed, and the
contents were drained out, collected, and centrifuged at
2500 rpm for 10 min. The volume and pH of the gastric
juice was measured and was subjected to free and total
acidity estimation according to the method described by
Srivastava et al. [16]. Free acidity was determined by
titration with 0.01 N sodium hydroxide (NaOH) with
methyl orange reagent until the color of the solutionbecame yellowish. The volume of alkali added was
noted. Then, two to three drops of phenolphthalein was
added and the solution was titrated until a definite pink
colour appears. The total volume of NaOH added was
noted and this corresponds to total acidity. Acidity was
calculated using the following formula:
Acidity ¼ Volume of NaOH normality of NaOH 100
0:1
meq=1Estimation of gastric wall mucus content Gastric wall
mucus content was determined by the method described
by Corne et al. [17] with slight modifications. The stom-
ach was opened along the greater curvature, weighed,
and immersed in 10 ml of 0.1% Alcian Blue in 0.16 M
sucrose/0.05 M sodium acetate, pH 5.8 for 2 h. The ex-
cessive dye was then removed by two successive rinses
in 0.25 M sucrose solution (15 min each). The remaining
dye complexed with the gastric mucus were extracted
with 0.5 M MgCl2 for 2 h and shaken intermittently for
1 min in every 30 min interval. The blue extract was
then shaken vigorously with an equal volume of diethyl
ether and the resulting emulsion was centrifuged at
3600 rpm for 10 min. The absorbance (OD) of Alcian
Blue in the aqueous layer was read at 580 nm using a
spectrophotometer. The quantity of Alcian Blue extract
per gram wet stomach was then calculated from a stand-
ard curve.
Ethanol-induced gastric mucosal lesion in L-NAME
pre-treated rats The involvement of endogenous NO in
modulating the ethanol-induced gastroprotective activity
was determined according to the method of Andreo
et al. [18], but with slight modifications. Male rats were
randomly divided into twelve groups (n = 6) and fasted
for 24 h but allowed free access to water. They were
then pre-treated with saline or L-NAME (70 mg/kg; an
inhibitor of NO synthase) intraperitoneally (i.p.) and
30 min later, the animals received vehicle (10% DMSO),
100 mg/kg CBX (positive control group) or 500 mg/kg
MEMM (p.o.). One hour after the administration of test
solutions, gastric ulcer was induced using 5 mL/kg ab-
solute ethanol in all groups. On the other hand, L-
Arginine (200 mg/kg) was administered, 30 min after
saline or L-NAME treatment and, followed 30 min later
by the ethanol administration. All rats were sacrificed
1 hr later by exposure to diethyl ether. The stomach
was opened along the greater curvature to determine
the ulcer area (UA) as described by Balan et al. [19].
The percentage protection was calculated using the fol-
lowing formula:
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Ethanol-induced gastric mucosal lesion in NEM pre-
treated rats To investigate the involvement of sulfhydryl
(SH) group in the modulation of ethanol-induced gastro-
protective activity, the procedures described by Andreo
et al. [18] were adopted with slight modifications. The
rats were randomly divided into 12 groups (n = 6) and
fasted for 24 h but allowed free access to water. The
experiment started with pre-treatment (i.p.) of saline or
NEM (10 mg/kg), a sulfhydryl (SH-) blocker. Thirty min
after the pre-treatment regiment, the rats were adminis-
tered (p.o.) with vehicle (10% DMSO), 100 mg/kg CBX
(positive control group) or 500 mg/kg MEMM followed
by the administration of 5 mL/kg ethanol an hour later
to induce gastric ulceration. All animals were sacrificed
1 h after receiving ethanol by exposure to diethyl ether.
The stomach was removed and gastric damage was
determined as described above.
Biochemical analysis of stomach tissues
Following the macroscopic analyses, superoxide dismut-
ase (SOD) [20], catalase (CAT) [21], myeloperoxidase
(MPO) [22], glutathione peroxidase (GTP) [23], glutathi-
one reductase (GTR) [24] and thiobarbituric acid react-
ive substances (TBARS) [25] enzyme activities in the
rat’s stomach tissues were measured. The gastric mucosa
was scraped from the antral portion of the stomach
using a scrapper and stored at 4°C for biochemical estima-
tion. The scrapped gastric mucosa was subjected to
prepare the mucosal homogenate (pH 7.2). The hom-
ogenate was then centrifuged at 3000 rpm for 10 min
and the supernatant obtained was used for analysis of
antioxidant type on ethanol induced gastric mucosal
damage. In all antioxidant defense assays, ranitidine
(100 mg/kg)-pretreated group was considered as the
positive control group.
Determination of SOD activity
The activity of SOD was determined based on the inhib-
ition of the formation of nicotinamide adenine dinucleo-
tide, phenazine methosulfate and amino blue tetrazolium
formazan [20]. Approximately 0.5 ml of tissue hom-
ogenate was mixed with 0.4 ml of ethanol and chloro-
form mixture and centrifuged. To the supernatant,
assay mixture (sodium pyrophosphate buffer (0.025 M,
pH 8.3), nitroblue tetrazolium, phenazine methosul-
phate and reduced nicotinamide adenine dinucleotide
(NADH)) was added and incubated at 30°C for 90 s.
The reaction was arrested by the addition of glacial
acetic acid and mixed with n-butanol. The intensity ofthe colour developed in butanol was measured at
560 nm. The SOD activity was measured by the degree
of inhibition of this reaction and is expressed as milli-
mole/min/mg protein.
Determination of CAT activity
The activity of CAT was assayed colorimetrically at 620 nm
as described by the method of Sinha [21]. The reaction
mixture of 1.5 ml containing 1.0 ml phosphate buffer
(0.01 M, pH 7.0), 0.4 ml of 2.0 M H2O2 and 1.0 ml of tissue
homogenate. The reaction was stopped by the addition of
2.0 ml of dichromate–acetic acid reagent (5% potassium
dichromate and glacial acetic acid mixture in the ratio of
1:3). Results are expressed as millimole/min/mg protein.
Determination of MPO activity
The activity of MPO was measured according to the
method described by Bradley et al. [22] but with slight
modifications. The homogenized samples were frozen and
thawed for three times and centrifuged at 1500 g for
10 min at 40°C. Approximately 100 μl of the homogenized
supernatant was added to 1.9 ml of 10 mmol/L phosphate
buffer (pH 6.0) and 1.0 ml of 1.5 mmol/L O–dianisidine
hydrochloride containing 0.0005% (w/v) H2O2. The
absorbance was evaluated at 450 nm on a UV spectro-
photometer and the MPO activity in gastric tissues was
expressed as μmoles/min/mg protein.
Determination of GTP activity
The activity of GTP was measured by the method de-
scribed by Rotruck et al. [23] with slight modifications.
The reaction mixture, which contained 0.2 ml of 0.4 M,
Tris - HCl buffer, pH 7.0, 0.1 ml of 10 mM sodium
azide, 0.2 ml of tissue homogenate (homogenized the tis-
sue in 0.4 M Tris–HCl buffer, pH 7.0), 0.2 ml glutathi-
one and 0.1 ml of 0.2 mM hydrogen peroxide was then
incubated at room temperature for 10 min. The reac-
tion was arrested by the addition of 0.4 ml of 10% TCA
and subjection to the centrifugation process. The
supernatant was assayed for glutathione content by
using Ellmans reagent (19.8 mg of 5, 5′–dithiobisnitro
benzoic acid (DTNB) in 100 ml of 0.1% sodium nitrate).
A molar extinction coefficient of 6.22 × 103 μmol was
used to determine the activity of GTP. The enzyme ac-
tivity was expressed as international units of enzymatic
activity/g of protein. International units are expressed
as μmoles of hydroperoxides transformed/min/ml of
enzyme.
Determination of GTR activity
The level of GTR was determined by the method of
Ellman [24]. Approximately1.0 ml of supernatant was
treated with 0.5 ml of Ellmans reagent (19.8 mg of 5,
5′–dithiobisnitro benzoic acid (DTNB) in 100 ml of
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(0.2 M, pH 8.0). The absorbance was read at 412 nm
and the GTR activity was expressed as μmoles/min/mg
tissue.Determination of TBARS content
The extent of LPO was measured by analyzing the levels
of TBARS in the gastric mucosa according to the previ-
ous method [25] but with minor modification. To 0.5 ml
of tissue homogenate, 1.5 ml of 20% acetic acid, 0.2 ml
of SDS and 1.5 ml of TBA were added. The mixture was
made up to 4 ml with distilled water and heated for
1 hour at 95°C. After cooling, 4.0 ml of butanol–pyridine
mixture was added and shaken well. This mixture was
then centrifuged at 4000 rpm for 10 min. The organic
layer was taken and its absorbance was read at 532 nm
and the results were expressed as n mol/g protein.Estimation of protein
The protein content in the gastric tissue was estimated
according to the method of Lowry et al. [26] but with
slight modifications. The tissue sample and the stan-
dards (1.0 mg/ml Bovine serum albumin in double dis-
tilled water) in different tubes were treated with 5.0 ml
of reagent mixture (48% sodium potassium tartarate, 2%
copper sulphate and 3% sodium carbonate in 1:48 (v/v)).
Then Folin phenol reagent (1:2) was added to the reac-
tion mixture and allowed to stand for 30 min at room
temperature. The optical density was read at 710 nm
using water as reagent blank.In vitro anti-inflammatory activity of MEMM
In-vitro effect of MEMM on nitric oxide
Cell culture and stimulation The RAW 264.7 cell line
(murine monocytic macrophages) (European Collection
of Cell Cultures, Porton Down, UK) was sustained in
DMEM supplemented with 10% FBS, 4.5 g/L glucose,
L-glutamine (2 mM), sodium pyruvate (1 mM), penicil-
lin (50 U/ml) and streptomycin (50 μg/ml) and 5% CO2
at 37°C. The cells (4 × 105 cells/well) were seeded into a
96-well plate and incubated for 2 h at 37°C in a CO2
incubator to allow the attachment of cells, and then
triggered with stimuli (100 U/ml of IFN-g and 5 μg/ml
of LPS) with or without the presence of MEMM in the
concentration ranging between 12.5-100 μg/ml. DMSO
(vehicle) was used to dissolve the MEMM. The final
concentration of DMSO was ensured to be 0.1% in all
cultures. Cells were then incubated for 17–20 h at 37°C in
a CO2 incubator. The NO determination was performed
by subjecting the cultured supernatant against the Griess
assay and the cells remaining in the well were tested for
cell viability assay.Nitrite determination
The concentration of nitrite (NO2
−), a stable metabolite
of NO in culture medium, was determined using the
Griess assay [27]. An equal volume of Griess reagent
was mixed with the culture supernatant and the color
development was measured at 550 nm. The quantity of
nitrite in the culture supernatant was determined based
on the standard curve of a sodium nitrite (0–100 μM)
freshly prepared in deionized water. Percentage of the
NO inhibition was calculated by using the formula
below:
NO inhibitory %ð Þ ¼ NO2




*control is the nitrite level of IFN-γ/LPS-induced
group.Cell viability
The cytotoxicity of MEMM on the cultured cells was de-
termined by assaying the reduction of 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT)
[27]. The MTT reagents (0.05 mg/ml) were suspended
in sterile PBS, pH 7.0 and then added into each well sub-
sequent to removing the supernatant. This was followed
by the incubation of the remaining cells at 37°C for 4 h
followed by the addition of 100 μl of 100% DMSO into
the wells to dissolve the formazan salts formed. The ab-
sorbance was measured at 570 nm. The percentage of
cell viability was calculated according to the following
formula:
Cell viability %ð Þ ¼ ODcontrol  –ODsample
ODcontrol  100%
where;
*control is the nitrite level of IFN-γ/LPS-induced
groupIn vitro effect of MEMM on lipoxygenase activity
The ability of MEMM to exert an inhibitory effect
against lipoxygenase activity was determined using the
spectrophotometric method [28]. 160 μl sodium phos-
phate buffer (0.1 M, pH 8.0), 10 μl of MEMM and 20 μl
of soybean lipoxygenase solution were combined and in-
cubated for 10 min at 25°C. This was followed by the
addition of 10 μl of the sodium linoleic acid solution
(substrate) to initiate the reaction. The enzymatic activity
converted linoleic acid to (9Z, 11E)-(13S)-13-hydroperox-
yoctadeca-9,11-dienoate, which was accompanied by the
change of absorbance measured at 234 nm for the period
Zakaria et al. BMC Complementary and Alternative Medicine  (2015) 15:135 Page 7 of 15of 6 min. MEMM and reference standards were dissolved
in methanol. All reactions were performed in triplicates in
a 96-well microplate.
In vitro effect of MEMM on xanthine oxidase activity
The ability of MEMM to inhibit xanthine oxidase activity
was measured using the mspectrophotometric method
[29]. 130 μl potassium phosphate buffer (0.05 M, pH 7.5),
10 μl of the MEMM and 10 μl of xanthine oxidase solution
were combined and incubated for 10 min at 25°C followed
by the initiation of reaction by the addition of 100 μl of
xanthine solution (substrate). The enzymatic action con-
verted xanthine to form uric acid and hydrogen peroxides
was measured at absorbance of 295 nm. MEMM and refer-
ence standards were dissolved in DMSO. All reactions
were performed in triplicates in a 96-well UV microplate.
Evaluation of the pharmacological potential of quercitrin
The ability of quercitrin to exert gastroprotective, anti-
oxidant and anti-inflammatory activities were measured
using the respective assay to support its role in the
modulation of MEMM gastroprotective activity.
Statistical analysis
The results obtained were analyzed using One-way ana-
lysis of variance (ANOVA), followed by Dunnett’s post
hoc test or the Newman-Keuls test and expressed as
mean ± S.E.M. The statistical software used to analyze
the data was SPSS version 15. Results were considered
significant when p <0.05.
Results
Phytochemical constituents and HPLC profile of MEMM
The extract demonstrated the presence of flavonoids,
triterpenes, tannins, saponins and steroids, but not alka-
loids, which is similar to the phytochemicals presence in
the dried leaves.
The phytochemicals analysis of MEMM was carried
out using the HPLC method and following several trials
at different wavelengths, the phytochemicals profile of
MEMM was best isolated at the wavelength of 300 nm
(Figure 1A). At the wavelength of 300 nm, 7 major peaks
were clearly separated from the MEMM at the retention
time (RT) of 14.355, 18.146, 18.575, 18.894, 19.395,
21.047, and 23.657 min. In order to predict the class of
compounds present in MEMM, further analysis were
carried out to determine the range of λmax value of the
seven peaks. As can be seen in Figure 1B, the λmax value
for the four peaks falls in the regions of 206.1-279.1,
217.8-273.2, 219.8-269.7, 219.0-349.4, 254.3-357.7 and
255.5-349.4 nm, respectively. An attempt to determine
the presence of some of the well-known flavonoids
shows that only quercitrin was found in the MEMM at
the tested wavelength (Figure 1C).Possible mechanisms of gastroprotection of MEMM and
quercitrin
Effects of MEMM on pyloric ligation-induced gastric ulcer:
the macroscopic andmicroscopic findings
Table 1 shows the parameters measured from the gastric
content following the pyloric ligation-induced gastric ulcer
assay. Ranitidine and MEMM exerted significant (p < 0.05)
antisecretory activity by reducing the volume of gastric
juice collected. In addition, the extract increased the pH of
gastric content towards alkaline level and the gastric wall
mucus content while reducing the total and free acidity
when compared to the control group. Quercitrin, at 50 and
250 mg/kg, also exerted gastroprotective activity by signifi-
cantly (p < 0.05) increasing the pH and, total and free
acidity. Moreover, quercitrin also significantly (p < 0.05)
increased the gastric wall mucus production (Table 1).
Ethanol-induced gastric mucosal lesion in L-NAME or NEM
pre-treated rats
As shown in Table 2 and Figure 2, pre-treatment with
L-NAME and NEM augmented the ulcerative index in-
duced by ethanol in comparison to group pre-treated with
saline in 10% DMSO-treated group (Figure 2A(1–3)). More-
over, pre-treatment with L-NAME and NEM caused signifi-
cant (p < 0.05) reduction in CBX- induced gastroprotection
(Figure 2B(1–3)). On the other hand, pre-treatment
with L-NAME and NEM caused significant (p < 0.05) in-
crease in the ulcer area formation when compared to their
respective counterpart pre-treated with normal saline
(Figure 2C(1–3)). Quercitrin exerted significant (p < 0.05)
gastroprotective activity, which was also significantly (p <
0.05) attenuated by L-NAME and NEM (2D(1–3)).
Effect of MEMM on biochemical parameters of stomach
tissue
Further attempt was also made to investigate the role of
enzymatic and non-enzymatic antioxidant defenses on
the ulceration development in all gastric tissues wherein
the antioxidant levels of SOD, CAT, MPO GTP and
GTR activity were determined. Table 3 shows the effect
of MEMM on the level of SOD, CAT and MPO enzymes
in rats subjected to the ethanol-induced gastric ulcer.
The gastric ulcer induced group (negative control)
showed significant (P < 0.05) decrease in SOD activity in
comparison to the normal control (ethanol-untreated)
group, which was reversed by the 250 and 500 mg/kg
MEMM, and 30 mg/kg lansoprazole. As for the CAT
level, the negative control group significantly (P < 0.05)
increased the enzyme level but was reduced by both
concentrations of MEMM as well as lansoprazole. On
the other hand, the MPO level significantly (P < 0.05) in-
creased in ethanol-administrated group in comparison
to the normal control group. Pretreatment with MEMM, at






































































































Figure 1 HPLC profile of MEMM at the wavelength 254 nm. A. HPLC analysis of MEMM at wavelength 254 nm shows 7 major peaks that were
clearly separated at the retention time (RT) of 14.355, 18.146, 18.575, 18.894, 19.395, 21.047, and 23.657 min. B: Further HPLC analysis was carried
out to determine the range of λmax value of the 7 respective peaks detected in MEMM. The chromatogram demonstrates that the λmax value
for the six respective peaks falls in the regions of 206.1-279.1, 217.8-273.2, 219.0, 217.8-269.7, 254.3-357.7 and 255.5-349.4 nm, respectively,
suggesting, in part the presence of flavonoid-based compounds. Comparison between chromatogram of the standard flavonoid with the
chromatogram of MEMM at 300 nm showed the possible presence of quercitrin, which corresponds to peak 7.C: Comparison between HPLC
chromatogram of MEMM and quercitrin at 300 nm shows that quercitrin was present in MEMM. The peak that was produced by quercitrin
corresponds to peak 7 of MEMM.
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Gastric juice Gastric wall mucus
Volume (ml) pH Total acidity (meq/l) Free acidity (meq/l) Alcian blue μg/g wet tissue
Pylorus ligation 10% DMSO - 5.83 ± 1.01 1.50 ± 0.09 5427.00 ± 380.40 4367.00 ± 573.30 85.68 ± 13.76
Ranitidine 100 1.63 ± 0.30a 4.41 ± 0.76b 1433.00 ± 92.15c 1500.00 ± 235.20d 241.30 ± 14.11*
MEMM 50 6.50 ± 0.52 1.82 ± 0.12 3100.00 ± 392.30c 2420.00 ± 438.80d 151.26 ± 32. 17*
250 2.58 ± 0.61a 2.43 ± 0.22b 3107.00 ± 458.00c 2040.00 ± 327.60d 354.24 ± 38.71*
500 1.95 ± 0.16a 3.55 ± 0.63b 3105.00 ± 435.2c 933.30 ± 291.90d 422.08 ± 67.73*
Quercitrin 50 4.31 ± 0.74a 2.38 ± 0.23b 4648.00 ± 223.50c 3211.00 ± 261.60d 258.63 ± 17.48*
250 4.72 ± 0.38a 4.43 ± 0.16b 3519.00 ± 380.40c 2367.00 ± 382.80d 407.42 ± 21.76*
a,b,c,d,Data with different superscript differed significantly (p < 0.05) when compared to the 10% DMSO-pretreated group within the respective column.
*Data differed significantly (p < 0.05) when compared to the 10% DMSO-pretreated group within the respective column.
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ethanol administration. Quercitrin significantly (p < 0.05)
increased the level of antioxidant enzymes namely SOD
but reduced the level of CAT and MPO (Table 3).
Table 4 shows the effect of MEMM on the level
of GSH, namely GTP and GTR, and TBARS in rats sub-
jected to the ethanol-induced gastric ulcer. Rats in the
negative control group exhibited significant (P < 0.05) de-
crease in GTP and GTR levels when compared to the
normal untreated group. On the other hand, MEMM, at
the dose of 250 and 500 mg/kg, was found to reverse theTable 2 Effects of the MEMM on gastric lesions induced
by ethanol in rats pretreated with L- NAME or NEM
Pre-treatment Treatment Dose, mg/kg Ulcer area (mm2)
Saline 10% DMSO - 33.33 ± 1.84
CBX 100 3.17 ± 0.31a
MEMM 500 0.83 ± 0.40a
Quercitrin 250 mg/kg 1.62 ± 0.74a
L-NAME 10% DMSO - 49.38 ± 3.64b
CBX 100 mg/kg 7.00 ± 0.76ce
MEMM 500 mg/kg 5.25 ± 0.98cf
Quercitrin 250 mg/kg 22.48 ± 1.93cg
NEM 10% DMSO - 61.50 ± 4.62b
CBX 100 mg/kg 12.00 ± 2.46dh
MEMM 500 mg/kg 54.33 ± 4.82di
Quercitrin 250 mg/kg 38.85 ± 5.21dj
Values are mean ± SEM (n = 6 rats/group).
One-way ANOVA followed by Student–Newman–Keuls.
a,bData differed significantly (p < 0.05) when compared to the (saline + 10%
DMSO)- pretreated group.
cData differed significantly (p < 0.05) when compared to the (L-NAME + 10%
DMSO)- pretreated group.
dData differed significantly (p < 0.05) when compared to the (NEM + 10%
DMSO)- pretreated group.
e,hData differed significantly (p < 0.05) when compared to the
(saline + CBX)-pretreated group.
f,iData differed significantly (p < 0.05) when compared to the
(saline + MEMM)-pretreated group.
g,jData differed significantly (p < 0.05) when compared to the
(saline + quercitrin)-pretreated group.ethanol effect and caused significant (P < 0.05) increase
in GTP level but decrease in GTR level. The same obser-
vations were not seen with the standard drug, 30 mg/kg
lansoprazole. Ethanol alone was found to significantly
(P < 0.05) increase the TBARS level when compared to
the normal untreated control group wherein both doses
of MEMM, but not 30 mg/kg ranitidine, significantly
(P < 0.05) reversed the ethanol-induced increases in TBARS
level. Quercitrin also significantly i(p < 0.05) increased the
level of antioxidant exzymes GTP and GTR while at the
same time reduced the level of non-enzymatic oxidative
component such as m TBARS (Tables 3 and 4).
In vitro anti-inflammatory activity of MEMM
Cell viability and NO production
The in vitro effect of MEMM (12.5-100 μg/ml) on per-
centage of RAW 264.7 cell viability and NO production
determined using the MTT assay is shown in Figure 3.
The results showed that the MEMM, at all concentra-
tions, did not affect cell viability. The extract was found
to significantly (p < 0.05) increased the percentage of in-
hibition of NO production in LPS-induced RAW 264.7
cells. The amount of nitrite, a stable metabolite of NO,
was used as the indicator of NO production in the
medium. L-NAME, a standard NOS inhibitor, caused a
significant inhibition of NO (p < 0.05). Quercitrin, on the
other hand, also did not affect cell viability but caused
significant (p < 0.05) inhibition of NO production.
Effect of MEMM on lipoxygenase and xanthine oxidase
activities
MEMM was found to exert anti-inflammatory activity
when assessed using the in vitro lipoxygenase and xanthine
oxidase assays. At the concentration of 100 μg/ml, MEMM
showed high inhibitory activity against the lipoxygenase
assay, but low inhibitory effect against the xanthine oxidase
assay (Table 5). Quercitrin exerted high inhibitory effect








Figure 2 Gross examination of the gastric mucosa of rats treated with 10% DMSO-, CBX- or MEMM following pretreatment with saline, L-NAME
or NEM, respectively. A. Gross examination of the gastric mucosa in rats. A1, A2 and A3 represent the control (10% DMSO) group pre-treated with
saline, L-NAME (70 mg/kg) or NEM (10 mg/kg), respectively. Pre-treatment with L-NAME or NEM in control group aggravated the lesion formation
as compared to saline pre-treated control group. B: Gross examination of the gastric mucosa in rats treated with CBX (100 mg/kg). B1, B2 and B3
represent the positive control group pre-treated with saline, L-NAME (70 mg/kg) or NEM (10 mg/kg), respectively. Pre-treatment with L-NAME or
NEM in positive control group significantly reversed the gastroprotection activity of CBX.C: Gross examination of the gastric mucosa in rats treated
with MEMM (500 mg/kg). C1, C2 and C3 represent the groups pre-treated with saline, L-NAME (70 mg/kg) or NEM (10 mg/kg), respectively. The
gastroprotective effect exerted by MEMM against ethanol-induced damage was reversed by the pre-treatment of L-NAME or NEM, suggesting the
involvement of nitric oxide and sulfhydryl compounds in the gastroprotection conferred by MEMM.
Table 3 Effect of methanol extract of M. malabathricum leaves (MEMM), quercitrin and ranitidine on levels of
superoxide dismutase (SOD), catalase (CAT) and myeloperoxidase (MPO) enzymes in rats of ethanol-induced gastric
tissues
Experimental groups SOD (mmol/min/mg of protein−1) CAT (mmol/min/mg protein−1) MPO (UI mg of protein−1)
Normal (Untreated) 53.26 ± 2.93 5.04 ± 0.87 1.76 ± 0.28
Negative Control (Ethanol) 38.73 ± 4.81* 7.17 ± 0.72* 3.52 ± 0.23*
100 mg/kg Ranitidine + Ethanol 58.72 ± 5.80# 5.11 ± 0.74# 2.23 ± 0.18#
250 mg/kg MEMM+ Ethanol 42.38 ± 3.25 6.08 ± 0.59 2.88 ± 0.45#
500 mg/kg MEMM+ Ethanol 50.31 ± 6.06# 5.32 ± 0.31# 2.11 ± 0.28#
50 mg/kg Qurcitrin + Ethanol 55.83 ± 4.22# 5.18 ± 1.01# 1.94 ± 0.63#
250 mg/kg Qurcitrin + Ethanol 52.89 ± 5.09# 5.41 ± 0.83# 1.61 ± 0.19#
*significant at p < 0.05 when compared against the normal (untreated) group using the Student’s t-test.
#significant at p < 0.05 when compared against the negative control (ethanol-treated) group using the ANOVA followed by Dunnett’s test.
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Table 4 Effect of methanol extract of M. malabathricum leaves (MEMM), quercitrin and ranitidine on levels of
glutathione peroxidase (GTP), glutathione reductsase (GTR) and thiobarbituric acid reactive substances (TBARS) in rats
of ethanol-induced gastric tissues
Experimental groups GTP (nmol min−1 mg
of protein−1)
GTR (nmol min−1 mg
of protein−1)
TBARS (nmol TBARS−1 mg
of protein1)
Normal (Untreated) 316.22 ± 52.77 28.37 ± 0.91 2.81 ± 0.23
Negative Control (Ethanol) 127.83 ± 20.84* 12.74 ± 0.77* 6.27 ± 0.56*
100 mg/kg Ranitidine + Ethanol 186.81 ± 26.73# 14.39 ± 1.96 4.13 ± 1.07#
250 mg/kg MEMM+ Ethanol 271.56 ± 41.31# 15.62 ± 1.01# 4.29 ± 0.33#
500 mg/kg MEMM+ Ethanol 310.18 ± 30.07# 18.86 ± 2.34# 3.01 ± 0.92#
50 mg/kg Qurcitrin + Ethanol 201.16 ± 13.45# 17.33 ± 0.84# 3.17 ± 0.12#
250 mg/kg Qurcitrin + Ethanol 308.24 ± 22.87# 25.76 ± 1.41# 2.25 ± 0.33#
The results were expressed as mean ± SEM.
*significant at p < 0.05 when compared against the normal (untreated) group using the Student’s t-test.
#significant at p < 0.05 when compared against the negative control (ethanol-treated) group using the ANOVA followed by Dunnett’s test.
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The present study aimed to investigate the gastroprotec-
tive mechanisms of MEMM using the pylorus ligation
model. This is one of the most widely used gastroprotec-
tive model to study the effect of drugs on gastric acid and
mucus secretion. An increase in gastric hydrochloric acid
(HCl) secretion and/or stasis of acid cause auto digestion
of the gastric mucosa and breakdown of the gastric muco-
sal barrier in the pylorus-ligated animals [30]. Agents that
reduce secretion of gastric aggressive factors such as
pepsin and acid (antisecretory) and/or increase mucin
secretion (cytoprotective) are effective gastroprotective
agents [10]. In the present study, the ability of MEMM
to exert gastroprotective effect was proven via the extract
ability to reduce the pH and acidity (total and free), but
increase the volume of gastric juice secretion.
Moreover, the extract was also able to increase the re-
lease of gastric wall mucus secretion. Mucus is secreted
by the mucus neck cells and coats the gastric mucosa
[31]. There are several mechanisms involved to increaseFigure 3 Effect of MEMM on the nitric oxide (NO) production and RAW 26
was followed by Dunnett’s post hoc test, *p < 0.05 shows significant differenc
group). 200 μM L-NAME.gastroprotection via increased mucus secretion, which
include improving the buffering of acid in gastric juice,
lessening of stomach wall friction during peristalsis and
gastric contractions, and by acting as an effective barrier
to back diffusion of hydrogen ions [32]. The ability of
MEMM to increase the amount of gastric mucus wall
content proves that enhancement of the gastric mucosal
defense action could be one of the possible mechanism
of gastroprotection exerted by MEMM.
In addition, the role of nitric oxide (NO) and sulfhy-
dryl group in the modulation of gastroprotective activity
exerted by MEMM was also proven using the ethanol-
induced gastric ulcer model. The gastroprotective effect
exerted by MEMM against ethanol-induced damage was
reversed by the pre-treatment of L-NAME, an inhibitor
of NO synthase, suggesting that the low level of NO trig-
gered by L-NAME administration reduced the extract’s
gastroprotective potential. This finding indicates the im-
portant and possible participation of NO in the gastro-
protective effect shown by MEMM. NO is considered4.7 cells’ viability. The assays were done in triplicate. One way ANOVA
e as compared to the IFN-γ/LPS-treated group (inflammation induced
Table 5 Effect of MEMM and quercitrin on the in vitro
lipoxygenase and xantine oxidase activities
Sample Concentration
(μg/ml)
Lipoxygenase (%) Xanthine oxidase (%)
MEMM 100 82.12 ± 3.29 (H) 32.53 ± 4.50 (L)
Quercitrin 100 9.07 ± 1.12 (L) 58.79 ± 6.11 (M)
All values are expressed as mean ± SEM.
Note: H-high (71-100%); M-moderate (41-70%); L-low (0-40%); NA-not active.
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in the gastric mucosa [33]. NO plays an important role
in the modulation of gastric mucosal integrity against
hyperacidity or exposure to ulcerogens and in regulating
acid secretion [34]. It also helps in maintaining the gas-
tric mucosal blood flow, barrier function and alkaline
production [35].
On the other hand, pre-treatment of NEM, a SH
blocker, alone increased the area of ulcer formation
when assessed using the ethanol-induced gastric ulcer
model and, when pre-challenged with MEMM reversed
the extract’s gastroprotective potential. These findings
suggested that the sulfhydryl group is important in the
attenuation of gastric ulcer formation and that the absence
of sulfhydryl group following the NEM administration re-
duce the extract’s ability to exert gastroprotective activity.
These observations suggest that the gastroprotection
showed by MEMM depends on the presence of mucosal
SH compound levels. Endogenous SH compounds are key
agents in mucosal protection against ethanol-induced
gastric injury [36]. The development of ethanol-induced
gastric damage is accompanied by a decrease in mucosal
sulfhydryl compounds because these compounds are
neutralized when they bind to the free radicals pro-
duced by injured tissues [37]. Therefore, the SH com-
pounds provide protective effects through binding free
radicals formed following the ethanol treatment and by
controlling the production of mucus [38]. In addition,
SH compounds are also involved in the maintenance of
the mucus disulfide bridges that connects the mucus
subunits. In the condition where the disulfide bridges
are damaged, the mucus would become more soluble,
resulting in a gastric mucosa that is more susceptible to
injuries [39].
Moreover, various mechanisms of defense against
toxicity and tissue damage triggered by ROS have been
reported. These mechanisms involving enzymatic and non-
enzymatic systems have been investigated and their in-
volvements are proven. The enzymatic and non-enzymatic
antioxidant defenses comprise SOD, CAT, GTP, GTR, β-
tocopherol, vitamin C, β-carotene and vitamin A. These
antioxidants also take part in the prevention of gastric
damage [23,40,41]. SOD, regarded as the first line of
defense against the harmful effects of oxygen radicals inthe cells, forages ROS by catalyzing the dismutation of
superoxide to H2O2 [42]. Previous study reported that
ethanol depresses SOD activities [43] leading to failure
of the body defense mechanism to convert superoxide
radicals to H2O2. It is suggested that inhibition of SOD
activity cause an increase flux of superoxide radicals in
cellular compartments, which may explain the increased
in lipid peroxidative indices in the present study. CAT, a
highly reactive enzyme that reacts with H2O2 to form
water and molecular oxygen, plays a protective antioxi-
dant effect against the deleterious actions of lipid perox-
idation. Ethanol increased CAT activity when given
alone, which was reversed following pretreatment with
MEMM or ranitidine. The increased CAT activity in
group treated only with ethanol could be related to in-
crease formation of H2O2 from superoxide radicals by
SOD. Thiobarbituric acid reactive substances (TBARS)
are byproduct of lipid peroxidation, which is produce
upon oxidative injury induced by ethanol. Excessive
generation of free radicals (i.e. hydroxyl ethyl radical,
superoxide radical (O2−), hydroxyl radical (OH−), peroxyl
radical and hydrogen peroxide) occur as a result of ethanol
administration [44]. These free radicals have a high ten-
dency to react swiftly with lipids, thus, triggering lipid
peroxidation, a process that can lead to membrane
disorganization and consequently reduces in membrane
fluidity [45]. The ethanol-induced increases in TBARS
level was reversed by MEMM and ranitidine suggesting
reduction in the lipid peroxidation activity upon the
oral administration of MEMM or the standard drug.
Glutathione (GT), a powerful nucleophilic antioxidant,
plays multiple roles such as serving as an electron donor
for certain antioxidative enzymes, maintaining cells in a
reduced state, and critical for cellular protection (i.e.
detoxification of ROS, control of inflammatory cytokines
and, conjugation and excretion of toxic molecules) [46].
Reduction of GTR in tissues initiates impairment of the
cellular protections against ROS and may result in peroxi-
dative injury [47]. Administration of ethanol alone was
found to triggered reduction in the level of GTR while
pretreatment with MEMM or ranitidine reversed the etha-
nol effect and, therefore, increase the GTR level. This
finding indicates the ability of MEMM to restore the re-
duced GTR levels for efficient cellular defense against the
action of free radicals. GTP, on the other hand, is essen-
tials in the elimination of H2O2 and lipid hydroperoxides
in gastric mucosal cells and also plays role in the mainten-
ance of a constant ratio of reduced glutathione to oxidized
glutathione in the cell [48]. GTP activity was reduced in
group that received only ethanol but was reversed by
MEMM or ranitidine suggesting that the gastroprotective
activity of MEMM may appear through glutathione me-
tabolism. Lastly, myeloperoxidase (MPO) is a sensitive
and specific tissue marker enzyme for acute inflammation
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[49]. Tissue MPO increased in ethanol-administered rat
stomach tissues in comparison to the normal untreated
rats. This increase in MPO activity may be linked to
increase in the levels of neutrophil infiltration and
H2O2 in the ethanol-induced gastric damaged tissues.
In the present study, MEMM and ranitidine demon-
strated a tendency to counter the increase in MPO level
caused by ethanol. Other than the modulation of
enzymatic and non-enzymatic antioxidant defenses as
described above, the extract potential as antioxidant
agent may also contributes to the observed gastropro-
tective activity [7]. Various reports have showed the
effectiveness of pretreatment of scavengers of reactive
oxygen species in attenuating most of the gastric muco-
sal injury suggesting that the antioxidant effect is one of
the most important mechanisms of gastroprotective
activity [50,51].
The ability of MEMM to exert anti-inflammatory
activity was proven via its ability to exert inhibitory
action against the LOX and XO activities. The im-
portant of LOX in the attenuation of gastric ulcer has
been reported elsewhere [52], as the leucotrienes play
an important role in blood coagulation and GIT irri-
tation [53]. Thus, inhibition of 5-LOX will be helpful
in attenuating the formation of gastric ulcer during
long term therapy of non-selective and COX-1 select-
ive NSAID’s.
The gastroprotective potential of MEMM could also
be attributed to the presence of various phytochemical
constituents isolated and identified from different
parts of M. malabathricum. In the present study, we
have shown the presence of at least quercitrin in
MEMM using the HPLC method. We have tested and
showed the ability of quercitrin to exert antiulcer, anti-
oxidant and anti-inflammatory activities. These findings
were constant to previous reports on pharmacological
activities of quercitrin. Quercitrin has been reported to
exert intestinal anti-inflammatory effect via inhibition
of iNOS expression [54]. Later, quercitrin, following
conversion into quercetin after glycoside’s cleavage by
the intestinal microbiota, was reported to exert in vivo
anti-inflammatory activity in the experimental model of
rat colitis induced by dextran sulfate sodium via the in-
hibition of the NF-jB pathway [55]. Recently, quercitrin,
isolated from Ixora coccinea, was reported to exert
remarkable antioxidant activity with low IC50 when
assessed using the DPPH radical scavenging and nitric
oxide scavenging assays [56]. Moreover, quercitrin,
isolated from Panicum virgatum, has been reported to
inhibit lipid peroxidation when assessed using the thio-
barbituric acid reactive substances (TBARS) assay [57].
Based on those reports, it is plausible to suggest that
the antiulcer activity of MEMM was partly attributedto the anti-inflammatory and antioxidant activities of
quercitrin present in the extract.
Conclusion
In conclusion, our present study shows that the MEMM
exerted gastroprotective activity through various mecha-
nisms, including the antisecretory and cytoprotective ac-
tivities and, the enzymatic (such as SOD, CAT, GTP and
myeloperoxidase) and non-enzymatic (such as anti-lipid
peroxidation) antioxidant defense mechanisms. More-
over, modulation of NO and SH compounds also con-
tributes to the gastroprotection mechanism conferred by
MEMM. In addition, the high antioxidant activity, high
total phenolic content and synergistic activity of various
phytochemcial constituents could also be another mech-
anism in which MEMM exerts its protective activity.
Further studies are being carried out in our laboratory
to isolate and identify the bioactive compound(s) re-
sponsible for the gastroprotective activity of MEMM.
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